China Advanced Care Gateway
Precision Oncology
NGS, molecular profiling and biomarker-driven review to support individualised medication strategies, interpreted by hospital molecular tumour boards.
What this pathway covers
- Next-generation sequencing (NGS)
- Molecular profiling
- Targeted therapies
- Biomarker-driven treatment
- Individualised medication strategies
- Precision cancer treatment review
Other pathways
CrossCare Global is a healthcare coordination platform. It is not a hospital and does not diagnose, treat or determine clinical eligibility. Treatment availability and eligibility depend on individual medical evaluation, hospital acceptance, regulatory requirements and current clinical protocols. Nothing here guarantees admission, treatment outcomes or visa approval.